Name: 耐多药结核病患者就医与治疗路径：中国东部宁波市区域健康信息系统真实世界数据分析
Creator: Taylor & Francis
License: CC BY 4.0

基本信息

模态

表格

大小

0.000039899 GB

许可

CC BY 4.0

创建/更新时间

2026-01-21

版本

v1

资源简介

耐多药结核病患者就医与治疗路径：中国东部宁波市区域健康信息系统真实世界数据分析

【一句话概览】

本研究基于宁波地区卫生信息系统真实数据，分析2015—2019年240例耐多药结核病（MDR-TB）患者求医与治疗路径。结果显示，初次就诊选择非结核定点机构者占55%，高于定点机构45%；约69%患者首次就诊接受结核筛查；47%患者需就诊4—7家机构才确诊。80%（192例）在四次就诊内确诊，13%、4%、3%患者第四次未确诊，分别（来源 figshare，CC BY 4.0 许可）。

【数据集背景】

本数据集源站标题为《Care-seeking and treatment pathways of multidrug-resistant tuberculosis patients: an analysis of real-world data from regional health information system in Ningbo City in Eastern China》。配套论文《Care-seeking and treatment pathways of multidrug-resistant tuberculosis patients: an analysis of real-world data from regional health information system in Ningbo City in Eastern China》发表于 Annals of Medicine（2025），DOI：10.1080/07853890.2025.2496405。项目资助方：This work was supported by the National-Zhejiang Health Commission Major S&T Project (grant number WKJ-ZJ-2118), Zhejiang Provincial Medical and Health Project(Grant Nos. 2023KY645) and the Health Commission of Zhejiang Province [2023KY642].。源站首次发布：2025-12-21。

【数据内容】

源站原始描述：The patient pathway of multidrug-resistant tuberculosis (MDR-TB) in China is an essential but not well-studied area. This study aimed to understand the alignment between patient-initiated care-seeking demands for MDR-TB and the availability of diagnostic and treatment services in Ningbo, a city in eastern China, using patient pathway analysis (PPA). We collected the diagnostic and treatment data of 240 patients with MDR-TB in Ningbo from 2015 to 2019. Using patient pathway analysis, we matched t…

【数据结构与技术规格】

文件数 3 个，合计 39.90 KB。iann_a_2496405_sm9532.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，15.11 KB。iann_a_2496405_sm9531.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，11.54 KB。iann_a_2496405_sm9530.docx：application/vnd.openxmlformats-officedocument.wordprocessingml.document，13.26 KB。数据集 DOI：10.6084/m9.figshare.30928079.v1。

【主题与分类】

源站学科分类：Medicine、Microbiology、Cell Biology、Genetics、Biotechnology、Environmental Sciences not elsewhere classified。主题标签：Multidrug-resistant tuberculosis、patient pathway analysis、real-world、care seeking、ningbo。

【适用方向】

结构化表格数据可直接用于统计建模、特征工程与队列分析。

【获取与许可】

源站页面：https://tandf.figshare.com/articles/dataset/Care-seeking_and_treatment_pathways_of_multidrug-resistant_tuberculosis_patients_an_analysis_of_real-world_data_from_regional_health_information_system_in_Ningbo_City_in_Eastern_China/30928079

使用许可：CC BY 4.0（https://creativecommons.org/licenses/by/4.0/）。

规范引用：Care-seeking and treatment pathways of multidrug-resistant tuberculosis patients: an analysis of real-world data from regional health information system in Ningbo City in Eastern China. Taylor & Francis. Chen, Bin; Li, Yang; Peng, Ying; Zhou, Lin; Chen, Xin-yi; Ren, Yan-li; et al

【使用注意】

· 源站最后修改于 2026-01-21，引用时请注意版本时效。

原始链接

https://tandf.figshare.com/articles/dataset/Care-seeking_and_treatment_pathways_of_multidrug-resistant_tuberculosis_patients_an_analysis_of_real-world_data_from_regional_health_information_system_in_Ningbo_City_in_Eastern_China/30928079/1

访问原始数据

官方服务

专家保障全链路合规授权与标注交付

陕川双基地 × 超十家三甲医院直连

从合规授权、采集治理、专业标注到数据集交付，我们提供全链路闭环服务，让高质量临床数据即拿即用。

⚡️ 需要原始数据或标注支持？联系我们获取定制方案。

帮我联系

下载信息

注册下载

需要注册 Kaggle 账号并登录后下载，适合需要跟踪下载记录和使用 API 的用户。

暂未开放

公开下载

无需注册即可直接获取公开样本或文档，适合快速预览和评估数据集质量。

免登录

有偿下载

公开数据集受托下载与技术交付服务。

提供高速下载与技术交付服务（收技术服务费，非数据销售）

暂未开放

当前数据集主要来源为 Kaggle 公开托管，完整影像包建议通过原始链接或 Kaggle API 获取。

使用方式

数据集获取（Figshare）

源站标题：Care-seeking and treatment pathways of multidrug-resistant tuberculosis patients: an analysis of real-world data from regional health information system in Ningbo City in Eastern China
DOI：10.6084/m9.figshare.30928079.v1
发布日期：2025-12-21
文件数：3 个
文件总体积：39.90 KB
源站页面：https://tandf.figshare.com/articles/dataset/Care-seeking_and_treatment_pathways_of_multidrug-resistant_tuberculosis_patients_an_analysis_of_real-world_data_from_regional_health_information_system_in_Ningbo_City_in_Eastern_China/30928079

命令行下载

curl -L -o "iann_a_2496405_sm9532.docx" "https://ndownloader.figshare.com/files/60533072"
curl -L -o "iann_a_2496405_sm9531.docx" "https://ndownloader.figshare.com/files/60533075"
curl -L -o "iann_a_2496405_sm9530.docx" "https://ndownloader.figshare.com/files/60533078"

文件清单

iann_a_2496405_sm9532.docx（15.11 KB）
iann_a_2496405_sm9531.docx（11.54 KB）
iann_a_2496405_sm9530.docx（13.26 KB）

文件总体积 39.90 KB（源站 API 实测）。

数据说明

The patient pathway of multidrug-resistant tuberculosis (MDR-TB) in China is an essential but not well-studied area. This study aimed to understand the alignment between patient-initiated care-seeking demands for MDR-TB and the availability of diagnostic and treatment services in Ningbo, a city in eastern China, using patient pathway analysis (PPA).
We collected the diagnostic and treatment data of 240 patients with MDR-TB in Ningbo from 2015 to 2019. Using patient pathway analysis, we matched the medical data of patients from different medical institutions and mapped their care pathways to illustrate their access to medical services.
Our study indicated that the proportion of patients with MDR-TB who chose non-TB-designated medical institutions (55%) was higher than those who chose TB-designated medical institutions (45%) at their initial visit. An estimated 69% of patients with MDR-TB patients received initial TB screening services during their first visit. In this study, 47% of patients needed to visit 4–7 medical institutions to be diagnosed with MDR-TB. Overall, 80% (n = 192) of patients were diagnosed with MDR-TB within four visits, while 13% (n = 30), 4% (n = 10), and 3% (n = 8) of patients were not diagnosed at the fourth visit and remained at level 2, 1, and 0 medical institutions, respectively.
The care-seeking pathway of patients with MDR-TB in Ningbo is complex. This indicates room for improvement in local diagnosis and referral services. There is a need to promote the deployment of MDR-TB screening, diagnosis, and treatment services at lower-level institutions.